Laura Kline
6Patents
3h-index
12Co-inventors
50Inventor score
Filing activity: Jun 10, 2003 → Aug 25, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8512727B2 | Nanoparticulate meloxicam formulations | Emerging Cross-Sectional Technologies | 106 | Expired |
| US7763278B2 | Nanoparticulate polycosanol formulations and novel polycosanol combinations | Human Necessities | 36 | Expired |
| US10463673B2 | Nanoparticulate meloxicam formulations | Human Necessities | 3 | Active |
| US7998507B2 | Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors | Human Necessities | 2 | Active |
| US10709713B2 | Nanoparticulate meloxicam formulations | Human Necessities | 0 | Active |
| US10471067B2 | Nanoparticulate meloxicam formulations | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.